Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Nipro ( (JP:8086) ).
Nipro Corporation reported its consolidated financial results for the three months ended June 30, 2025, showing a 4.5% increase in net sales and a 24.6% rise in operating profit compared to the previous year. Despite these gains, the company experienced a significant decline in ordinary profit by 45.2%, reflecting challenges in its operations. The financial forecast for the fiscal year ending March 31, 2026, anticipates continued growth in net sales and operating profit, indicating a positive outlook for stakeholders.
The most recent analyst rating on (JP:8086) stock is a Buy with a Yen1600.00 price target. To see the full list of analyst forecasts on Nipro stock, see the JP:8086 Stock Forecast page.
More about Nipro
Nipro Corporation is a company listed on the Tokyo Stock Exchange, operating in the healthcare industry. It specializes in manufacturing and distributing medical devices, pharmaceutical products, and glass products, focusing on improving patient care and medical outcomes.
Average Trading Volume: 539,690
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen226.5B
See more insights into 8086 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money